Name | Number of supported studies | Average coverage | |
---|---|---|---|
Mueller cell | 4 studies | 51% ± 8% |
Insufficient scRNA-seq data for expression of CPA6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 405.42 | 239 / 245 | 68% | 3.64 | 339 / 502 |
intestine | 97% | 98.94 | 933 / 966 | 43% | 3.13 | 227 / 527 |
esophagus | 86% | 42.88 | 1242 / 1445 | 31% | 1.92 | 57 / 183 |
uterus | 72% | 50.88 | 123 / 170 | 33% | 2.28 | 152 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.10 | 1 / 1 |
bladder | 57% | 95.86 | 12 / 21 | 27% | 1.59 | 136 / 504 |
lung | 36% | 9.06 | 207 / 578 | 36% | 1.98 | 420 / 1155 |
stomach | 25% | 4.82 | 90 / 359 | 33% | 2.35 | 95 / 286 |
kidney | 15% | 3.90 | 13 / 89 | 29% | 0.70 | 263 / 901 |
pancreas | 3% | 0.57 | 10 / 328 | 38% | 2.29 | 68 / 178 |
breast | 18% | 5.90 | 83 / 459 | 22% | 4.47 | 249 / 1118 |
spleen | 40% | 10.01 | 97 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.34 | 16 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 5.03 | 8 / 29 |
adipose | 19% | 3.92 | 225 / 1204 | 0% | 0 | 0 / 0 |
skin | 12% | 4.53 | 219 / 1809 | 1% | 0.08 | 6 / 472 |
ovary | 8% | 2.46 | 14 / 180 | 4% | 0.11 | 17 / 430 |
muscle | 9% | 1.24 | 70 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 9% | 0.75 | 35 / 406 |
brain | 5% | 0.81 | 121 / 2642 | 3% | 0.13 | 23 / 705 |
blood vessel | 5% | 0.99 | 68 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 0.43 | 9 / 258 | 1% | 0.02 | 3 / 230 |
eye | 0% | 0 | 0 / 0 | 4% | 0.07 | 3 / 80 |
thymus | 1% | 0.11 | 5 / 653 | 0% | 0.01 | 2 / 605 |
peripheral blood | 0% | 0.05 | 3 / 929 | 0% | 0 | 0 / 0 |
heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | CPA6 |
Protein name | Carboxypeptidase A6 (EC 3.4.17.-) |
Synonyms | CPAH |
Description | FUNCTION: May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II . Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine . . |
Accessions | ENST00000479862.6 [Q8N4T0-3] ENST00000297770.10 [Q8N4T0-1] Q8N4T0 ENST00000638254.1 [Q8N4T0-3] |